We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRG icon
526
Kite Realty
KRG
$5.86B
$1.05M 0.01%
49,117
-301,351
-86% -$6.82M
RIVN icon
527
Rivian
RIVN
$23.6B
$1.05M 0.01%
43,125
– –
CPAY icon
528
Corpay
CPAY
$25.7B
$1.04M 0.01%
4,090
– –
HON icon
529
Honeywell
HON
$76.4B
$1.04M 0.01%
5,968
-72
-1% -$13.2K
COR icon
530
Cencora
COR
$62B
$1.03M 0.01%
5,720
-712
-11% -$131K
BLDR icon
531
Builders FirstSource
BLDR
$7.29B
$1.03M 0.01%
8,250
-888
-10% -$123K
RCKT icon
532
Rocket Pharmaceuticals
RCKT
$343M
$1.02M 0.01%
50,000
– –
DRI icon
533
Darden Restaurants
DRI
$24.3B
$1.02M 0.01%
7,108
-687
-9% -$109K
TDY icon
534
Teledyne Technologies
TDY
$29.2B
$994K 0.01%
2,434
– –
MRO
535
DELISTED
Marathon Oil Corporation
MRO
$976K 0.01%
36,483
-32,211
-47% -$833K
BBY icon
536
Best Buy
BBY
$19B
$976K 0.01%
14,044
– –
LVS icon
537
Las Vegas Sands
LVS
$32.2B
$970K 0.01%
21,157
-25,760
-55% -$1.39M
TW icon
538
Tradeweb Markets
TW
$23B
$950K 0.01%
11,848
-1,236
-9% -$98.5K
MCHP icon
539
Microchip Technology
MCHP
$38.8B
$941K 0.01%
12,056
-1,499
-11% -$125K
RHI icon
540
Robert Half
RHI
$4.11B
$939K 0.01%
12,808
– –
IVZ icon
541
Invesco
IVZ
$12.4B
$935K 0.01%
64,418
-5,700
-8% -$91.7K
BNS icon
542
Scotiabank
BNS
$105B
$933K 0.01%
20,725
-8,188
-28% -$392K
AVTR icon
543
Avantor
AVTR
$9.82B
$932K 0.01%
44,233
– –
BXP icon
544
Boston Properties
BXP
$11.6B
$925K 0.01%
15,546
-3,596
-19% -$230K
STLD icon
545
Steel Dynamics
STLD
$36.4B
$920K 0.01%
8,579
-2,244
-21% -$234K
BEN icon
546
Franklin Resources
BEN
$16.8B
$918K 0.01%
37,328
+609
+2% +$16.5K
GPC icon
547
Genuine Parts
GPC
$17.9B
$912K 0.01%
6,316
-742
-11% -$115K
EQH icon
548
Equitable Holdings
EQH
$13.2B
$902K 0.01%
31,776
– –
ALGN icon
549
Align Technology
ALGN
$12.9B
$899K 0.01%
2,944
– –
ESS icon
550
Essex Property Trust
ESS
$19.1B
$891K 0.01%
4,200
-433
-9% -$102K
20 21
22
23 24

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.